As shown in Fig. 4f, g, while there was strong expression of p16 protein in the benign lesions, the expression was lost in the malignant tumors, indicating that loss of p16 expression maybe required for the benign lesions to escape a quiescent state and evolve into malignant tumors. The gene discussed is CDKN2A; the disease is cancer.